Skip to content

LSD and psychedelic-assisted therapy: all studies

Page 6 of 6: studies 51 to 55 of 55, newest first. Back to the LSD and psychedelic-assisted therapy overview

Research

LSD-Assisted Psychotherapy in Patients with Terminal Cancer

International Pharmacopsychiatry 1973 Stanislav Grof, Louis E. Goodman, William A. Richards et al. 212 citations

The paper describes the results of a clinical study exploring the potential of a complex psychotherapeutic program utilizing psychedelic compounds to alleviate the emotional and physical suffering of cancer patients. A total of 60 cancer patients participated in this experimental study. In 44 of these patients, LSD (200-500 p%per os) was administered as an adjunct to psychotherapy; in 19...

DOI: 10.1159/000467984 (opens in new tab) Terminal cancer Terminal telecommunication Psychotherapist Terminal care

Psychedelic Therapy Utilizing LSD in the Treatment of the Alcoholic Patient: A Preliminary Report

American Journal of Psychiatry April 1, 1967 Albert A. Kurland, Sanford M. Unger, John W. Shaffer et al. 56 citations

The rationale of psychedelic therapy with alcoholic patients is focused on the alienation-breaking potential of "peak" or psychedelic experiences induced with the aid of LSD. An exemplary LSD session report and MMPI data on 69 pilot patients are presented for illustration. While all present results indicate that psychedelic therapy does add significantly to presently available alcoholic...

Psychedelic Therapy: A Primer for Primary Care Clinicians-Lysergic Acid Diethylamide (LSD).

American Journal of Therapeutics Bryce D. Beutler, Kenneth Shinozuka, Burton J. Tabaac et al. 11 citations

Lysergic acid diethylamide (LSD) is a hallucinogenic agent. In the mid-20th century, it was used to augment psychoanalysis and to treat alcohol use disorder. However, LSD was banned in 1970 in part because of concerns that it could bring about or exacerbate mental illness. Its therapeutic potential remains incompletely understood. While uncontrolled recreational use of LSD can, in rare...

DOI: 10.1097/mjt.0000000000001726 (opens in new tab) Full text (opens in new tab) Psychedelic therapy Mental health treatment Anxiety disorders Clinical research +1

Psychedelic Therapy: A Primer for Primary Care Clinicians – Part II. Lysergic acid diethylamide (LSD)

Bryce D. Beutler, Kenneth Shinozuka, Burton J. Tabaac et al. preprint

Background: Lysergic acid diethylamide (LSD) is a hallucinogenic agent. In the mid-20th century, it was used to augment psychoanalysis and to treat alcohol use disorder. However, LSD was banned in 1970 in part due to concerns that it could bring about or exacerbate mental illness. Its therapeutic potential remains incompletely understood.Areas of Uncertainty: While uncontrolled recreational use...